Andson Biotech Inc. — Form D
Andson Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-26. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-03-26
- Form: D
- Accession: 0002017131-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Minimum investment: $5K
- Investors: 37
- Date of first sale: 2024-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508686
Issuer
- Name: Andson Biotech Inc.
- CIK: 0002017131
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1705 COMMERCE DR NW, ATLANTA, GA, 30318
- Phone: 7273897725
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Andrei Fedorov | Director | Atlanta, GA |
| Mason Chilmonczyk | Director | Atlanta, GA |
| Mason Chilmonczyk | Executive Officer | Atlanta, GA |
| Jim Filippini | Executive Officer | Atlanta, GA |
| Thomas O'Brien | Director | Jersey City, NJ |
| Glenn Epstein | Director | Atlanta, GA |
| James Ross | Director | Metairie, LA |
Other filings by this issuer (1)
More